Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2023-06-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury
NCT01512524
Comparison Between the IMPACT's Score and the Clinician's Perception to Predict the Prognosis of Severe and Moderate Traumatic Brain Injury
NCT03874546
Cerebral Desaturation in Traumatic Brain Injury
NCT02810145
A Study of Biomarkers of Mild Traumatic BRAIN Injury
NCT04032509
Morbidity and Mortality in Solo Adult Traumatic Brain Injury Patients in Minia University Hospital
NCT05075239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is particularly true in the case of traumatic brain injury , which is a high-incidence pathology with significant morbidity and mortality consequences that can lead to permanent sequelae . While research over the past 30 years has focused on the neuropsychological and functional outcomes of this event, less is known about the views of head injury survivors and their families on their quality of life, subjective well-being and related factors.
The aim of this study is to describe the quality of life of CT patients at least 6 months after the trauma. This assessment is related to the patient's degree of sequelae, using the Glasgow Outcome Scale Extended GOSE.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A bras actif
quality of life
To describe the relationship between distant sequelae of trauma assessed by the GOSE scale and quality of life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quality of life
To describe the relationship between distant sequelae of trauma assessed by the GOSE scale and quality of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Administration of Military Health, Tunisia
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hedi Gharsallah
DR Aicha REBAI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aicha N REBAI
Role: STUDY_CHAIR
hopital militaire de TUNIS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Military Hospital of Tunis
Tunis, Montfleury, Tunisia
Service de réanimation
Tunis, Montfleury, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QLTBIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.